Company
Cabaletta Bio
Cabaletta Bio has 4 drugs tracked on RxWires: 2 in Phase 2/3, 1 in Phase 1/2, 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| CABA-201 following preconditioning with fludarabine and cyclophosphamide | Phase 2/3 | Idiopathic Inflammatory Myopathy |
| CABA-201 | Phase 2/3 | Systemic Sclerosis |
| DSG3-CAART | Phase 1/2 | Pemphigus Vulgaris |
| MuSK-CAART | Phase 1 | MuSK Myasthenia Gravis |
Latest
- Fast Track Designation: cabaletta bio
- cabaletta bio filed 8-K
- cabaletta bio filed 8-K
- cabaletta bio filed 8-K
- cabaletta bio filed 8-K
Follow Cabaletta Bio on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.